Showing results (231-240 of 272) with videos related to
Sort By:
Pageof 28
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2025
Lobectomy Improves Disease-Free Survival Over Sublobar Resection for High-Risk Stage IA Non-Small Cell Lung CancerRaul Caso, Nanruoyi Zhou, Matthew Skovgard, et al.Respirology (Carlton, Vic.)|May 28, 2024
Determinants of radiation exposure during mobile cone-beam CT-guided robotic-assisted bronchoscopyOr Kalchiem-Dekel, Reza Bergemann, Xiaoyue Ma, et al.Lung Cancer (Amsterdam, Netherlands)|April 20, 2026
Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancersNanruoyi Zhou, Stella Tsui, Nicolas Toumbacaris, et al.The Journal of Thoracic and Cardiovascular Surgery|January 9, 2023
Feasibility of shape-sensing robotic-assisted bronchoscopy for biomarker identification in patients with thoracic malignanciesJames G Connolly, Or Kalchiem-Dekel, Kay See Tan, et al.The Annals of Thoracic Surgery|February 5, 2024
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung CancerElizabeth G Dunne, Cameron N Fick, James M Isbell, et al.British Journal of Anaesthesia|June 20, 2021
Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinomaJames G Connolly, Kay See Tan, Brooke Mastrogiacomo, et al.Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2020
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung AdenocarcinomaRaul Caso, Francisco Sanchez-Vega, Kay See Tan, et al.Annals of Surgery|February 2, 2023
Waiting to Operate: The Risk of Salvage EsophagectomyThomas Boerner, Caitlin Harrington, Kay See Tan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 11, 2021
Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung AdenocarcinomaDaniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.Pageof 28